Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
The clinical research organisation located in Hyderabad is a USFDA inspected facility
Subscribe To Our Newsletter & Stay Updated